Literature DB >> 10931153

Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).

P D Arkwright1, F Rieux-Laucat, F Le Deist, R F Stevens, B Angus, A J Cant.   

Abstract

Fas-mediated apoptosis may be one of the effector pathways leading to the elimination of virus-infected cells. Cytomegalovirus (CMV) infection in two brothers with Fas deficiency associated with autoimmunity and benign lymphoproliferation (ALPS) provided a unique opportunity to study the clinical course of CMV infection in children with defective apoptosis. The clinical courses of two brothers with autosomal dominant ALPS who were infected with CMV in the neonatal period are described. CMV was detected from throat and urine culture from the brothers. ALPS was confirmed by in vitro anti-CD95 MoAb-induced T lymphocyte apoptosis assay and subsequent sequencing and identification of mutations in the Fas gene. A de novo mutation in the Fas gene, leading to a truncated cytoplasmic Fas product, was associated with autosomal dominant ALPS in a mother and her two sons. Both boys had evidence of CMV infection acquired early in infancy which cleared by the age of 2-3 years. There were no neurodevelopmental sequelae. The natural history of CMV infection in two infants with ALPS was similar to that described in normal children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931153      PMCID: PMC1905690          DOI: 10.1046/j.1365-2249.2000.01304.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Early acquisition of cytomegalovirus infection.

Authors:  C S Peckham; C Johnson; A Ades; K Pearl; K S Chin
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

3.  Congenital and acquired cytomegalovirus infections. Virological and clinical studies on a Swedish infant population.

Authors:  K Ahlfors; S A Ivarsson; T Johnsson; I Svensson
Journal:  Acta Paediatr Scand       Date:  1978-05

4.  Maternal cytomegalovirus excretion and perinatal infection.

Authors:  D W Reynolds; S Stagno; T S Hosty; M Tiller; C A Alford
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

5.  Prevalence and duration of postnatally acquired human cytomegalovirus infection.

Authors:  J G Starr; E Gold
Journal:  J Chronic Dis       Date:  1970-02

6.  Chronic lymphadenopathy simulating malignant lymphoma.

Authors:  V C Canale; C H Smith
Journal:  J Pediatr       Date:  1967-06       Impact factor: 4.406

7.  Virus excretion and cell-mediated immunity during cytomegalovirus infection among healthy infants and children.

Authors:  R Tanaka; A Tanaka; Y Oizumi; N Ishida; Y Numazaki
Journal:  J Med Virol       Date:  1986-01       Impact factor: 2.327

8.  Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.

Authors:  J van der Werff ten Bosch; J Delabie; T Böhler; J Verschuere; K Thielemans
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

9.  The natural history of acquired cytomegalovirus infection among children in group day care.

Authors:  J R Murph; J F Bale
Journal:  Am J Dis Child       Date:  1988-08

10.  Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women.

Authors:  Y Numazaki; N Yano; T Morizuka; S Takai; N Ishida
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

View more
  3 in total

Review 1.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

2.  Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.

Authors:  Keiko Nomura; Hirokazu Kanegane; Keisuke Otsubo; Hiroshi Wakiguchi; Yukihiro Noda; Yoshihito Kasahara; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2011-05-28       Impact factor: 2.490

3.  Human cytomegalovirus suppresses Fas expression and function.

Authors:  Sepehr Seirafian; Virginie Prod'homme; Daniel Sugrue; James Davies; Ceri Fielding; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Gen Virol       Date:  2014-01-06       Impact factor: 3.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.